Coenzyme Q10 Ameliorates Pancreatic Fibrosis via the ROS-Triggered mTOR Signaling Pathway

Figure 2

(a) ROS levels were tested using flow cytometry by the DCFH-DA fluorescent probe. There were significant differences between the CoQ10-treated group and the CP group in terms of ROS levels (; ). (b) The MDA levels were reduced with CoQ10 treatment compared with the CP group (; ). (c) The GSH-PX levels were increased with CoQ10 treatment compared with the CP group (; ). (d) The SOD levels were increased with CoQ10 treatment compared with the CP group (; ).

(a)

(b)

(c)

(d)